[Federal Register Volume 60, Number 7 (Wednesday, January 11, 1995)]
[Notices]
[Pages 2781-2782]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-662]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
[GN# 2294]
National Vaccine Advisory Committee (NVAC), Subcommittee on
Future Vaccines, Public Meeting
AGENCY: Office of the Assistant Secretary for Health, HHS.
SUMMARY: The Department of Health and Human Services (DHHS) and the
Office of the Assistant Secretary for Health (OASH) are announcing the
forthcoming meeting of the Future Vaccines Subcommittee of the National
Advisory Committee.
DATES: Date, Time and Place: January 20, 1995, at 10:30 a.m. to 3:30
p.m., Conference Room 703A, Hubert H. Humphrey Building, 200
Independence Avenue, SW., Washington, DC 20201. The entire meeting is
open to the public.
FOR FURTHER INFORMATION CONTACT: Written requests to participate should
be sent to Chester A. Robinson, D.P.A., Acting Director, National
Vaccine Program Office, Rockwall II Building, Suite 1075, 5600 Fishers
Lane, Rockville, Maryland 20857, (301) 594-2277.
Agenda: Open Public Hearing: Interested persons may formally
present data, information, or views orally or in writing on issues to
be discussed by the Subcommittee. Those wishing to make presentations
should notify the contact person before January 16, and submit a brief
description of the information they wish to present to the
Subcommittee. Requests should include the names and addresses of
proposed participants. A maximum of 10 minutes will be allowed for a
given presentation, but the time may be adjusted depending on the
number of persons presenting. Any person attending the meeting who does
not request an opportunity to speak in advance of the meeting will be
allowed to make an oral presentation at the conclusion of the meeting,
if time permits, at the Chairperson's discretion.
Open Subcommittee Discussion: The Subcommittee is charged with
developing guidance that will lead to the development, licensure, and
best use of existing and new vaccines or vaccine combinations in the
simplest possible immunization schedules.
A list of Subcommittee members and the charter of the NVAC
Committee will be available at the meeting. Those unable to attend the
meeting may
[[Page 2782]]
request this information from the contact person.
Dated: January 4, 1995.
Jeanette R. DeLawter,
Acting Executive Secretary, NVAC.
[FR Doc. 95-662 Filed 1-10-95; 8:45 am]
BILLING CODE 4160-17-M
